Off the wire
• U.S. stocks rally after weak jobs data  • EU calls for closer cooperation on refugee crisis with Turkey  • 1st Ld: Chinese premier congratulates Tu Youyou on winning Nobel Prize for medicine  • Africa Economy: World Bank forecasts Africa's economy to slow in 2015  • Murder probe after police officer mown down in high-speed chase  • Syrian rebel groups call for alliance against Russian military intervention  • 1st Ld-Writethru: North China on yellow alert for smog  • China Open tennis results  • BiH coach expects tough game against Wales  • NATO chief expresses concern over Turkey situation  
You are here: 　 Home

Novozymes acquires U.S. probiotics maker

Xinhua, October 6, 2015 Adjust font size:

Industrial enzyme maker Novozymes of Denmark has acquired Pacific Vet Group-USA to strengthen position in probiotics for animals, the company announced Monday.

For an undisclosed value, Novozymes bought the Arkansas-based company that has significant know-how in animal health care.

Pacific Vet Group-USA's products are based on beneficial bacteria, mainly lactic acid bacteria, and technologies to improve gut health in poultry.

Novozymes is a leading global enzyme manufacturer, with a global market share of 48 percent.

The Copenhagen-based company first entered the probiotics for animals business in May, when it announced partnership with one of the biggest manufacturers of nutritional additives, Adisseo, to develop and market a probiotic for poultry. Probiotics are naturally occurring, live microbes that improve the gut flora of pigs, poultry and other animals.

Pacific Vet Group-USA, founded in 2008, has 23 employees, and its business is primarily in research and application development. Endit